Skip to content
BY-NC-ND 4.0 license Open Access Published by De Gruyter October 18, 2016

An Ontology for Description of Drug Discovery Investigations

  • Da Qi , Ross D. King , Andrew L. Hopkins , G. Richard J. Bickerton and Larisa N. Soldatova EMAIL logo

Summary

The paper presents an ontology for the description of Drug Discovery Investigation (DDI). This has been developed through the use of a Robot Scientist “Eve”, and in consultation with industry. DDI aims to define the principle entities and the relations in the research and development phase of the drug discovery pipeline. DDI is highly transferable and extendable due to its adherence to accepted standards, and compliance with existing ontology resources. This enables DDI to be integrated with such related ontologies as the Vaccine Ontology, the Advancing Clinico-Genomic Trials on Cancer Master Ontology, etc. DDI is available at http://purl.org/ddi/wikipedia or http://purl.org/ddi/home

Published Online: 2016-10-18
Published in Print: 2010-12-1

© 2010 The Author(s). Published by Journal of Integrative Bioinformatics.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Downloaded on 23.11.2024 from https://www.degruyter.com/document/doi/10.1515/jib-2010-126/html
Scroll to top button